Copyright
©The Author(s) 2025.
World J Gastrointest Pharmacol Ther. Dec 5, 2025; 16(4): 110472
Published online Dec 5, 2025. doi: 10.4292/wjgpt.v16.i4.110472
Published online Dec 5, 2025. doi: 10.4292/wjgpt.v16.i4.110472
Figure 1 Mechanism of action of Janus kinase inhibitors targeting the Janus kinase-signal transducers and activators of transcription pathway in immune modulation.
JAK: Janus kinase; IL: Interleukin; IFN: Interferon; GM-CSF: Granulocyte macrophage-colony stimulating factor; STAT: Signal transducers and activators of transcription.
- Citation: Ahsan MU, Sajid SL, Balach R, Daniyal M, Ain NU, Mudasir M. Emerging role of Janus kinase inhibitors in ulcerative colitis management. World J Gastrointest Pharmacol Ther 2025; 16(4): 110472
- URL: https://www.wjgnet.com/2150-5349/full/v16/i4/110472.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v16.i4.110472
